paxlovid pfizer - dofaq.co
Pfizer readies its next-generation COVID-19 antiviral
C&EN - 10 Mar 2025
Pfizer readies its next-generation COVID-19 antiviral ...
Enough Paxlovid to treat Covid-19 in at-risk adults, but it is no longer free: MOH
The Straits Times - 15 Dec 2024
Enough Paxlovid to treat Covid-19 in at-risk adults, but it is no longer free: MOH ...
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic
Nature - 20 Mar 2025
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic ...
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat
MarketWatch - 29 Apr 2025
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat ...
Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook
WSJ - 29 Apr 2025
Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook ...
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Reuters - 03 Feb 2025
Smaller US winter COVID wave adds pressure to Pfizer turnaround ...
Paxlovid: Impact on death, hospitalization rates in older vaccinated adults weaker than thought
UCLA - 20 Feb 2025
Paxlovid: Impact on death, hospitalization rates in older vaccinated adults weaker than thought ...
Fig. 4 | Pfizer global supply network map. Pfizer leveraged numerous...
researchgate.net - 24 Mar 2025
Fig. 4 | Pfizer global supply network map. Pfizer leveraged numerous... ...
Pfizer rides Paxlovid sales growth to better-than-expected third quarter
AP News - 29 Oct 2024
Pfizer rides Paxlovid sales growth to better-than-expected third quarter ...
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
Fierce Pharma - 04 Feb 2025
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet ...
Extended Course of Paxlovid May Help Some Patients With Long COVID
Pharmacy Times - 11 Jan 2025
Extended Course of Paxlovid May Help Some Patients With Long COVID ...
Paxlovid May Not Significantly Benefit Vaccinated Seniors, Study Says
Time Magazine - 21 Feb 2025
Paxlovid May Not Significantly Benefit Vaccinated Seniors, Study Says ...
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase
Yahoo Finance - 29 Oct 2024
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase ...
Pfizer notifies Seoul of plans to double Paxlovid's price, threatening Covid-19 treatment efforts
koreabiomed.com - 20 Aug 2024
Pfizer notifies Seoul of plans to double Paxlovid's price, threatening Covid-19 treatment efforts ...
Pfizer profits dip on lower Paxlovid sales
Digital Journal - 29 Apr 2025
Pfizer profits dip on lower Paxlovid sales ...
Pfizer CEO defends turnaround strategy as activist pressures management
Reuters - 29 Oct 2024
Pfizer CEO defends turnaround strategy as activist pressures management ...
Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard
Fierce Pharma - 29 Oct 2024
Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard ...
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study
Yahoo Finance - 06 Jan 2025
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study ...
Pfizer denies offering Seoul double Paxlovid’s supply price
koreabiomed.com - 21 Aug 2024
Pfizer denies offering Seoul double Paxlovid’s supply price ...